Having trouble accessing articles? Reset your cache.

Triggering myelin repair in MS

Researchers at the Cleveland Clinic and the University of California, Irvine have shown that knocking out CXC chemokine receptor 2 on oligodendrocytes improves myelin repair in two different mouse models of multiple sclerosis.1 The team thinks the receptor is an ideal target because it plays a role in two aspects of the disease: CNS inflammation and demyelination. However, finding antagonists that can cross the blood brain barrier could prove challenging.

The role of CXC chemokine receptor 2

Read the full 765 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers